BRPI0412130A - compostos tetracìclicos como inibidores de c-met - Google Patents

compostos tetracìclicos como inibidores de c-met

Info

Publication number
BRPI0412130A
BRPI0412130A BRPI0412130-9A BRPI0412130A BRPI0412130A BR PI0412130 A BRPI0412130 A BR PI0412130A BR PI0412130 A BRPI0412130 A BR PI0412130A BR PI0412130 A BRPI0412130 A BR PI0412130A
Authority
BR
Brazil
Prior art keywords
compounds
met
met inhibitors
tetracyclic compounds
tetracyclic
Prior art date
Application number
BRPI0412130-9A
Other languages
English (en)
Inventor
Tomas Vojkovsky
Marcel Koenig
Fang-Jie Zhang
Jingrong Cui
Original Assignee
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen Inc filed Critical Sugen Inc
Publication of BRPI0412130A publication Critical patent/BRPI0412130A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSTOS TETRACìCLICOS COMO INIBIDORES DE C-MET". A presente invenção refere-se a compostos de fórmulas (I) e (II), em que R~ 1~-R~ 10~ e G são definidos neste documento e os sais farmaceuticamente aceitáveis dos mesmos. Estes compostos modulam a atividade de c-Met e portanto espera-se que sejam úteis na prevenção e tratamento de distúrbios relacionados com c-Met, como seja o câncer.
BRPI0412130-9A 2003-07-02 2004-06-30 compostos tetracìclicos como inibidores de c-met BRPI0412130A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48422203P 2003-07-02 2003-07-02
US10/878,632 US7037909B2 (en) 2003-07-02 2004-06-29 Tetracyclic compounds as c-Met inhibitors
PCT/US2004/020929 WO2005004808A2 (en) 2003-07-02 2004-06-30 TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS

Publications (1)

Publication Number Publication Date
BRPI0412130A true BRPI0412130A (pt) 2006-08-15

Family

ID=34068190

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412130-9A BRPI0412130A (pt) 2003-07-02 2004-06-30 compostos tetracìclicos como inibidores de c-met

Country Status (6)

Country Link
US (1) US7037909B2 (pt)
JP (1) JP2007521299A (pt)
BR (1) BRPI0412130A (pt)
CA (1) CA2529323A1 (pt)
MX (1) MXPA06000166A (pt)
WO (1) WO2005004808A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108048A1 (en) * 2005-04-05 2006-10-12 The General Hospital Corporation Method for predicting responsiveness to drugs
PL1889836T3 (pl) 2005-08-24 2013-10-31 Eisai R&D Man Co Ltd Nowa pochodna pirydyny i pochodna pirymidyny (3)
HUE030390T2 (en) * 2005-12-21 2017-05-29 Janssen Pharmaceutica Nv Triazolopyridazines as tyrosine kinase modulators
MX2008011220A (es) 2006-03-07 2008-09-11 Array Biopharma Inc Compuestos de pirazol heterobiciclicos y metodos de uso.
JP2010500365A (ja) 2006-08-07 2010-01-07 インサイト・コーポレイション キナーゼ阻害剤としてのトリアゾロトリアジン
CN101454311B (zh) 2006-08-23 2013-03-27 卫材R&D管理有限公司 苯氧基吡啶衍生物的盐和其结晶及其制备方法
US7790885B2 (en) 2006-08-31 2010-09-07 Eisai R&D Management Co., Ltd. Process for preparing phenoxypyridine derivatives
ES2555803T3 (es) 2006-10-23 2016-01-08 Cephalon, Inc. Fusión de derivados bicíclicos 2,4-diaminopirimidina como utilizar inhibidores ALK y c-Met
ES2560435T3 (es) 2006-11-22 2016-02-19 Incyte Holdings Corporation Imidazotriazinas e imidazopirimidinas como inhibidores de la quinasa
JP2009132660A (ja) 2007-11-30 2009-06-18 Eisai R & D Management Co Ltd 食道癌治療用組成物
PE20091468A1 (es) 2008-02-28 2009-10-22 Novartis Ag DERIVADOS DE 3-METIL-IMIDAZO-[1,2-b]-PIRIDAZINA
US20110092452A1 (en) * 2008-03-05 2011-04-21 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating pancreatic cancer
MX393622B (es) 2008-05-21 2025-03-24 Incyte Corp Sales de 2-fluoro-n-metil-4-[7-(quinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamida y procesos relacionados con la preparacion de las mismas.
TW201035088A (en) 2009-02-27 2010-10-01 Supergen Inc Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
ES2441348T3 (es) 2009-12-18 2014-02-04 Basilea Pharmaceutica Ag Antibióticos tricíclicos
JP5714030B2 (ja) 2010-02-03 2015-05-07 インサイト コーポレーションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ Ｃ−Ｍｅｔ阻害剤としてのイミダゾ［１，２−ｂ］［１，２，４］トリアジン
CN102532141A (zh) 2010-12-08 2012-07-04 中国科学院上海药物研究所 [1，2，4]三唑并[4，3-b][1，2，4]三嗪类化合物、其制备方法和用途
JP2014517019A (ja) 2011-06-17 2014-07-17 バジリア ファルマスーチカ アーゲー 三環式抗生物質
WO2012178038A1 (en) 2011-06-24 2012-12-27 The Broad Institute, Inc. Methods of treating cancer
CN102503959B (zh) * 2011-10-25 2015-04-08 南方医科大学 一种稠三环类化合物及其制备方法、以及含该类化合物的药物组合物及其应用
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
CN104250257B (zh) * 2013-06-25 2017-06-16 上海翰森生物医药科技有限公司 3,4‑二氢‑1H‑苯并[c][1,2]噁硼酸类化合物或其可药用盐及其制备方法和用途
MX2016012285A (es) 2014-03-24 2017-01-23 Genentech Inc Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf.
WO2017049711A1 (zh) 2015-09-24 2017-03-30 上海海聚生物科技有限公司 喹啉类衍生物、其药物组合物、制备方法及应用
CN106278988A (zh) * 2016-08-12 2017-01-04 合肥久诺医药科技有限公司 一种溴芬酸钠杂质标准品的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1023205A (en) 1963-09-17 1966-03-23 Allen & Hanburys Ltd -triazino(5,6-6) indoles
CH606334A5 (pt) 1974-06-21 1978-10-31 Ciba Geigy Ag
US4159375A (en) 1978-08-24 1979-06-26 American Cyanamid Company 6- AND 7-Aryl-1,2,4-triazolo[4,3-b]-1,2,4-triazines
US4405619A (en) 1981-09-02 1983-09-20 Diamond Shamrock Corporation Antiinflammatory substituted-1,2,4-triazolo[4,3-b]-1,2,4-triazines
EP0717143A1 (de) 1994-12-16 1996-06-19 Lignozym GmbH Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
AU6357896A (en) 1996-06-19 1998-01-07 Hans-Peter Call Multicomponent system for use with detergent substances
DE19726241A1 (de) 1997-06-20 1998-12-24 Call Krimhild Erweitertes enzymatisches Multikomponentensystem zur Behandlung von Abwässern, zur Herstellung von Holzverbundstoffen, zum Deinken von Altpapier, Colour stripping von Altpapier, zum Einsatz als Oxidationssystem bei der organischen Synthese und zum Einsatz bei der Kohleverflüssigung

Also Published As

Publication number Publication date
JP2007521299A (ja) 2007-08-02
WO2005004808A3 (en) 2005-03-17
MXPA06000166A (es) 2006-04-27
US7037909B2 (en) 2006-05-02
CA2529323A1 (en) 2005-01-20
WO2005004808A2 (en) 2005-01-20
US20050014755A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
BRPI0514841A (pt) inibidores de piridila da sinalização de hedgehog, processo de preparação dos mesmos e composição compreendendo os referidos inibidores
BRPI0412040A (pt) hidrazidas de indolinona como inibidores de c-met
BRPI0417771A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóides
BR0317455A (pt) Derivados de pirrol-pirazol substituìdos como inibidores de quinase
BR0311806A (pt) Derivados heteroaril benzocondensado-amida de tienopiridinas úteis como agentes terapêuticos, composições farmacêuticas que os incluem e métodos para o seu uso
BRPI0412347A (pt) 2-aminofenil-4-fenilpiridinas como inibidores de quinase
BRPI0407976A (pt) tetrahidroisoquinolinas substituìdas em 2,5 e 2,6 para uso como moduladores de 5-ht6
BRPI0417820A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóide
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
BRPI0512237A (pt) cis-imidazolinas
BRPI0410760A (pt) compostos, processo para fabricação dos mesmos, composições farmacêuticas e uso deste compostos
BR0015254A (pt) Derivados de carbamoiloxialquil-azólio substituìdos em n
BR0309556A (pt) Inibidores de metaloproteinase pirimidina-2,4,6-triona
BR0308787A (pt) Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona
BRPI0416692A (pt) inibidores heterocìclicos de mek e métodos de emprego destes
BRPI0414011A (pt) naftalencarboxamidas e seus derivados úteis como novos agentes antiangiogênicos
BR0208192A (pt) Derivados espirotricìclicos e seu uso como inibidores da fosfodiesterase-7.
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
BRPI0410913A (pt) benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
BRPI0611923A2 (pt) modulaÇço sinergica da ftl3 quinase usando os moduladores de quinase aminoquinolina e aminoquinazolina
SE0401342D0 (sv) Therapeutic compounds

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]